Sitagliptin / Metformin hydrochloride Mylan Европейски съюз - български - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - metformin hydrochloride, sitagliptin hydrochloride monohydrate - Захарен диабет тип 2 - Лекарства, прилагани при диабет, - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. тройно комбинирано лечение) като допълнение към диета и упражнения при пациенти, недостатъчно контролирани за тяхното максимално переносимой дозата на метформина и сульфонилмочевины. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. ,

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Европейски съюз - български - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, метформин хидрохлорид - Захарен диабет тип 2 - Лекарства, прилагани при диабет , комбинация от устата на глюкозата в кръвта-лекарства за понижаване - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).

Metformin - Tchaikapharma 850 mg film-coated tablets България - български - Изпълнителна агенция по лекарствата

metformin - tchaikapharma 850 mg film-coated tablets

Чайкафарма Висококачествените лекарства АД - Метформин - 850 mg film-coated tablets

Segluromet Европейски съюз - български - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - Захарен диабет тип 2 - Лекарства, прилагани при диабет , комбинация от устата на глюкозата в кръвта-лекарства за понижаване - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Eucreas Европейски съюз - български - EMA (European Medicines Agency)

eucreas

novartis europharm limited - вилдаглиптин, метформин хидрохлорид - Захарен диабет тип 2 - Лекарства, прилагани при диабет , комбинация от устата на глюкозата в кръвта-лекарства за понижаване - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Competact Европейски съюз - български - EMA (European Medicines Agency)

competact

cheplapharm arzneimittel gmbh - пиоглитазон, метформин хидрохлорид - Захарен диабет тип 2 - Лекарства, прилагани при диабет, - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.